Safety and efficacy of combination therapy with pegylated interferon alpha-2a and ribavirin in treating patients with chronic hepatitis C and beta-thalassaemia major: a Greek single-center experience.
Title | Safety and efficacy of combination therapy with pegylated interferon alpha-2a and ribavirin in treating patients with chronic hepatitis C and beta-thalassaemia major: a Greek single-center experience. |
Publication Type | Journal Article |
Year of Publication | 2011 |
Authors | Paschos, P., Vlachaki E., Pasvanti C., Sinakos E., Kalpaka A., Klonizakis P., & Perifanis V. |
Journal | Acta Haematol |
Volume | 126 |
Issue | 4 |
Pagination | 231-3 |
Date Published | 2011 |
ISSN | 1421-9662 |
Keywords | Adult, Antiviral Agents, beta-Thalassemia, Blood Transfusion, Chelation Therapy, Drug Therapy, Combination, Female, Greece, Hepatitis C, Chronic, Homozygote, Humans, Interferon-alpha, Iron Chelating Agents, Iron Overload, Male, Middle Aged, Polyethylene Glycols, Recombinant Proteins, Ribavirin, Treatment Outcome |
DOI | 10.1159/000330516 |
Alternate Journal | Acta Haematol. |
PubMed ID | 21934299 |